Find a company
Search the SBRI Healthcare and NHS Cancer Programme Innovation Open call portfolio.
If you would like further information on any of the companies listed in the Directory please contact the SBRI Healthcare PMO by email sbri@lgcgroup.com or tel: +44 20 8843 8125.
We would be happy to make introductions to the companies or provide any further feedback you require.
At a glance
Directory search results
Taragenyx
| Project | Bioactive orthopaedic implant coatings – impregnation of surface with active pharmaceuticals |
|---|---|
| Description |
Taragenyx is a medical implant company developing a broad pipeline of bioactive, therapeutic and regenerative coatings for orthopaedic and dental implants. The technology delivers active pharmaceuticals and biologics locally from the implant surface post-operatively, thereby bringing the potential to; accelerate bone growth, drive faster healing and reduce the incidence of infection and pain. |
| Funding | £ 83,333 |
| Competition | Competition 7 - Musculoskeletal |
| Competition Date | May 2014 |
Peacocks Medical Group
| Project | Foot orthotic optimisation via finite element analysis and additive manufacturing (FootFEMan) |
|---|---|
| Description |
Peacocks Medical Group is combining existing orthotic designs with new additive manufacturing techniques. The aim of the project was to use finite element analysis (FEA) and additive manufacturing (AM) to develop and manufacture optimised foot orthotics for patients with pronation and supination issues. |
| Funding | £ 63,200 |
| Competition | Competition 7 - Musculoskeletal |
| Competition Date | May 2014 |
| Health Innovation Network Partner | |
| Website | http://www.peacocks.net/ |
Peacocks Medical Group
| Project | Optimised pads for foot orthoses (OPFO) |
|---|---|
| Description |
Foot orthoses (FO) are commonly used to reduce plantar pressure in diabetic feet. Peacock Medical Group’s project addresses the design and finite element optimisation of new kinds of FOs directly from 3D scan data and pressure measurements. The FOs would be manufactured directly via additive manufacturing (3D printing) utilising the design freedoms disruptive manufacturing processes provide. |
| Funding | £ 63,200 |
| Competition | Competition 8 - Improving the Care of the Diabetic Foot Ulcer: Better prevention, diagnosis, treatment |
| Competition Date | October 2014 |
| Categories | Diabetes |
| Health Innovation Network Partner | |
| Website | http://www.peacocks.net/ |